Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
Clinical trial NCT00422877 · TERMINATED
Trial details
- NCT number
- NCT00422877
- Sponsor
- American Regent, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-03-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.